Industry: Chemical & Material
Published Date: 2025-02-24
Pages: 101 Pages
Report ld: 3420355
Request Sample
Customized Report
Oligonucleotide Market Size(US$)

CAGR 2025-2031
10.1%
Market Size,2031
USD 2,967
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Oligonucleotide was valued at US$ 1527 million in the year 2024 and is projected to reach a revised size of US$ 2967 million by 2031, growing at a CAGR of 10.1% during the forecast period.
Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.
Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences. Solid-phase clinical synthesis is used to manufacture these small bits of nucleic acid for use in polymerase chain reaction (PCR), DNA sequencing, library construction and artificial gene synthesis.
Oligonucleotide drugs have the advantages of high therapeutic efficiency, low drug toxicity, and strong specificity, and have great potential in the treatment of metabolic diseases, genetic diseases, cancer, and prevention of infectious diseases. In recent years, due to the unique advantages of oligonucleotides in regulating gene expression, the research and development, production and commercialization of their drugs have developed rapidly, and the global market has continued to expand.
MARKET SEGMENTATION
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Oligonucleotide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oligonucleotide.
The Oligonucleotide market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oligonucleotide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oligonucleotide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oligonucleotide manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Oligonucleotide by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Oligonucleotide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Oligonucleotide Market Overview
1.1 Product Definition
1.2 Oligonucleotide by Type
1.2.1 Global Oligonucleotide Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 DNA
1.2.3 RNA
1.3 Oligonucleotide by Application
1.3.1 Global Oligonucleotide Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Gene Chip
1.3.3 Electrophoresis
1.3.4 Fluorescence In Situ Hybridization
1.4 Global Market Growth Prospects
1.4.1 Global Oligonucleotide Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Oligonucleotide Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Oligonucleotide Production Estimates and Forecasts (2020-2031)
1.4.4 Global Oligonucleotide Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Oligonucleotide Production Market Share by Manufacturers (2020-2025)
2.2 Global Oligonucleotide Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Oligonucleotide, Industry Ranking, 2023 VS 2024
2.4 Global Oligonucleotide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Oligonucleotide Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Oligonucleotide, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Oligonucleotide, Product Offered and Application
2.8 Global Key Manufacturers of Oligonucleotide, Date of Enter into This Industry
2.9 Oligonucleotide Market Competitive Situation and Trends
2.9.1 Oligonucleotide Market Concentration Rate
2.9.2 Global 5 and 10 Largest Oligonucleotide Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Oligonucleotide Production by Region
3.1 Global Oligonucleotide Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Oligonucleotide Production Value by Region (2020-2031)
3.2.1 Global Oligonucleotide Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Oligonucleotide by Region (2026-2031)
3.3 Global Oligonucleotide Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Oligonucleotide Production Volume by Region (2020-2031)
3.4.1 Global Oligonucleotide Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Oligonucleotide by Region (2026-2031)
3.5 Global Oligonucleotide Market Price Analysis by Region (2020-2025)
3.6 Global Oligonucleotide Production and Value, Year-over-Year Growth
3.6.1 North America Oligonucleotide Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Oligonucleotide Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Oligonucleotide Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Oligonucleotide Production Value Estimates and Forecasts (2020-2031)
4 Oligonucleotide Consumption by Region
4.1 Global Oligonucleotide Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Oligonucleotide Consumption by Region (2020-2031)
4.2.1 Global Oligonucleotide Consumption by Region (2020-2025)
4.2.2 Global Oligonucleotide Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Oligonucleotide Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Oligonucleotide Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Oligonucleotide Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Oligonucleotide Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Oligonucleotide Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Oligonucleotide Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Oligonucleotide Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Oligonucleotide Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Oligonucleotide Production by Type (2020-2031)
5.1.1 Global Oligonucleotide Production by Type (2020-2025)
5.1.2 Global Oligonucleotide Production by Type (2026-2031)
5.1.3 Global Oligonucleotide Production Market Share by Type (2020-2031)
5.2 Global Oligonucleotide Production Value by Type (2020-2031)
5.2.1 Global Oligonucleotide Production Value by Type (2020-2025)
5.2.2 Global Oligonucleotide Production Value by Type (2026-2031)
5.2.3 Global Oligonucleotide Production Value Market Share by Type (2020-2031)
5.3 Global Oligonucleotide Price by Type (2020-2031)
6 Segment by Application
6.1 Global Oligonucleotide Production by Application (2020-2031)
6.1.1 Global Oligonucleotide Production by Application (2020-2025)
6.1.2 Global Oligonucleotide Production by Application (2026-2031)
6.1.3 Global Oligonucleotide Production Market Share by Application (2020-2031)
6.2 Global Oligonucleotide Production Value by Application (2020-2031)
6.2.1 Global Oligonucleotide Production Value by Application (2020-2025)
6.2.2 Global Oligonucleotide Production Value by Application (2026-2031)
6.2.3 Global Oligonucleotide Production Value Market Share by Application (2020-2031)
6.3 Global Oligonucleotide Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Abbott Molecular
7.1.1 Abbott Molecular Oligonucleotide Company Information
7.1.2 Abbott Molecular Oligonucleotide Product Portfolio
7.1.3 Abbott Molecular Oligonucleotide Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Abbott Molecular Main Business and Markets Served
7.1.5 Abbott Molecular Recent Developments/Updates
7.2 PerkinElmer
7.2.1 PerkinElmer Oligonucleotide Company Information
7.2.2 PerkinElmer Oligonucleotide Product Portfolio
7.2.3 PerkinElmer Oligonucleotide Production, Value, Price and Gross Margin (2020-2025)
7.2.4 PerkinElmer Main Business and Markets Served
7.2.5 PerkinElmer Recent Developments/Updates
7.3 SciGene Corporation
7.3.1 SciGene Corporation Oligonucleotide Company Information
7.3.2 SciGene Corporation Oligonucleotide Product Portfolio
7.3.3 SciGene Corporation Oligonucleotide Production, Value, Price and Gross Margin (2020-2025)
7.3.4 SciGene Corporation Main Business and Markets Served
7.3.5 SciGene Corporation Recent Developments/Updates
7.4 Roche NimbleGen
7.4.1 Roche NimbleGen Oligonucleotide Company Information
7.4.2 Roche NimbleGen Oligonucleotide Product Portfolio
7.4.3 Roche NimbleGen Oligonucleotide Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Roche NimbleGen Main Business and Markets Served
7.4.5 Roche NimbleGen Recent Developments/Updates
7.5 CytoTest
7.5.1 CytoTest Oligonucleotide Company Information
7.5.2 CytoTest Oligonucleotide Product Portfolio
7.5.3 CytoTest Oligonucleotide Production, Value, Price and Gross Margin (2020-2025)
7.5.4 CytoTest Main Business and Markets Served
7.5.5 CytoTest Recent Developments/Updates
7.6 Oligo Factory
7.6.1 Oligo Factory Oligonucleotide Company Information
7.6.2 Oligo Factory Oligonucleotide Product Portfolio
7.6.3 Oligo Factory Oligonucleotide Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Oligo Factory Main Business and Markets Served
7.6.5 Oligo Factory Recent Developments/Updates
7.7 Danaher
7.7.1 Danaher Oligonucleotide Company Information
7.7.2 Danaher Oligonucleotide Product Portfolio
7.7.3 Danaher Oligonucleotide Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Danaher Main Business and Markets Served
7.7.5 Danaher Recent Developments/Updates
7.8 Thermo Fisher Scientific
7.8.1 Thermo Fisher Scientific Oligonucleotide Company Information
7.8.2 Thermo Fisher Scientific Oligonucleotide Product Portfolio
7.8.3 Thermo Fisher Scientific Oligonucleotide Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Thermo Fisher Scientific Main Business and Markets Served
7.8.5 Thermo Fisher Scientific Recent Developments/Updates
7.9 GE
7.9.1 GE Oligonucleotide Company Information
7.9.2 GE Oligonucleotide Product Portfolio
7.9.3 GE Oligonucleotide Production, Value, Price and Gross Margin (2020-2025)
7.9.4 GE Main Business and Markets Served
7.9.5 GE Recent Developments/Updates
7.10 Merck
7.10.1 Merck Oligonucleotide Company Information
7.10.2 Merck Oligonucleotide Product Portfolio
7.10.3 Merck Oligonucleotide Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Merck Main Business and Markets Served
7.10.5 Merck Recent Developments/Updates
7.11 Eurofins Scientific
7.11.1 Eurofins Scientific Oligonucleotide Company Information
7.11.2 Eurofins Scientific Oligonucleotide Product Portfolio
7.11.3 Eurofins Scientific Oligonucleotide Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Eurofins Scientific Main Business and Markets Served
7.11.5 Eurofins Scientific Recent Developments/Updates
7.12 Agilent
7.12.1 Agilent Oligonucleotide Company Information
7.12.2 Agilent Oligonucleotide Product Portfolio
7.12.3 Agilent Oligonucleotide Production, Value, Price and Gross Margin (2020-2025)
7.12.4 Agilent Main Business and Markets Served
7.12.5 Agilent Recent Developments/Updates
7.13 SUMITOMO CHEMICAL
7.13.1 SUMITOMO CHEMICAL Oligonucleotide Company Information
7.13.2 SUMITOMO CHEMICAL Oligonucleotide Product Portfolio
7.13.3 SUMITOMO CHEMICAL Oligonucleotide Production, Value, Price and Gross Margin (2020-2025)
7.13.4 SUMITOMO CHEMICAL Main Business and Markets Served
7.13.5 SUMITOMO CHEMICAL Recent Developments/Updates
7.14 Bachem
7.14.1 Bachem Oligonucleotide Company Information
7.14.2 Bachem Oligonucleotide Product Portfolio
7.14.3 Bachem Oligonucleotide Production, Value, Price and Gross Margin (2020-2025)
7.14.4 Bachem Main Business and Markets Served
7.14.5 Bachem Recent Developments/Updates
7.15 Sylentis
7.15.1 Sylentis Oligonucleotide Company Information
7.15.2 Sylentis Oligonucleotide Product Portfolio
7.15.3 Sylentis Oligonucleotide Production, Value, Price and Gross Margin (2020-2025)
7.15.4 Sylentis Main Business and Markets Served
7.15.5 Sylentis Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Oligonucleotide Industry Chain Analysis
8.2 Oligonucleotide Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Oligonucleotide Production Mode & Process Analysis
8.4 Oligonucleotide Sales and Marketing
8.4.1 Oligonucleotide Sales Channels
8.4.2 Oligonucleotide Distributors
8.5 Oligonucleotide Customer Analysis
9 Oligonucleotide Market Dynamics
9.1 Oligonucleotide Industry Trends
9.2 Oligonucleotide Market Drivers
9.3 Oligonucleotide Market Challenges
9.4 Oligonucleotide Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Oligonucleotide was estimated to be worth US$ 1666 million in 2025 and is projected to reach US$ 3237 million, growing at a CAGR of 10.1% from 2026 to 2032.
Published Date: 2026-07-14
Pages: 144
USD 3950.00
(Single User License)
The global Oligonucleotide market was valued at US$ 1666 million in 2025 and is anticipated to reach US$ 3237 million by 2032, at a CAGR of 10.1% from 2026 to 2032.
Published Date: 2026-04-27
Pages: 137
USD 2900.00
(Single User License)
The global Oligonucleotide market is projected to grow from US$ 1527 million in 2024 to US$ 2967 million by 2031, at a CAGR of 10.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 151
USD 4900.00
(Single User License)
The global Oligonucleotide market size was US$ 1527 million in 2024 and is forecast to a readjusted size of US$ 2967 million by 2031 with a CAGR of 10.1% during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 92
USD 4250.00
(Single User License)
The global market for Oligonucleotide was estimated to be worth US$ 1527 million in 2024 and is forecast to a readjusted size of US$ 2967 million by 2031 with a CAGR of 10.1% during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 114
USD 3950.00
(Single User License)
Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.
Published Date: 2024-01-16
Pages: 144
USD 3950.00
(Single User License)
Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.
Published Date: 2024-01-04
Pages: 110
USD 2900.00
(Single User License)
The global market for Oligonucleotide was estimated to be worth US$ 1666 million in 2025 and is projected to reach US$ 3237 million, growing at a CAGR of 10.1% from 2026 to 2032.
Published: 2026-07-14
Pages: 144
The global Oligonucleotide market was valued at US$ 1666 million in 2025 and is anticipated to reach US$ 3237 million by 2032, at a CAGR of 10.1% from 2026 to 2032.
Published: 2026-04-27
Pages: 137
The global Oligonucleotide market is projected to grow from US$ 1527 million in 2024 to US$ 2967 million by 2031, at a CAGR of 10.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 151
The global Oligonucleotide market size was US$ 1527 million in 2024 and is forecast to a readjusted size of US$ 2967 million by 2031 with a CAGR of 10.1% during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 92
The global market for Oligonucleotide was estimated to be worth US$ 1527 million in 2024 and is forecast to a readjusted size of US$ 2967 million by 2031 with a CAGR of 10.1% during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 114
Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.
Published: 2024-01-16
Pages: 144
Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.
Published: 2024-01-04
Pages: 110
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now